已收盘 12-19 16:00:00 美东时间
+0.139
+18.23%
(来源:蚌埠新闻网) 转自:蚌埠新闻网 立足监管、汇聚智慧、链接全球、共创未来。中国细胞与基因治疗领域迎来年度顶级盛会。 2025年9月12日至13日,202...
09-22 17:06
(来源:纪要头等座) 1、间充质干细胞商业化进展与挑战 ·国内首款干细胞药商业化现状:国内首款干细胞药方面,博生卓越已启动商业化进程,首例病人在前几个月完成注射...
07-31 18:18
Century Therapeutics will present two studies at the upcoming EULAR 2025 Congress in Barcelona, highlighting their iPSC-derived cell therapies for autoimmune diseases and cancer.
05-28 20:01
Century Therapeutics, Inc. (NASDAQ:IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology and autoimmune disease, today announced the
2024-09-26 19:07